In vitro metabolism of 2-(5-ethylpyridin-2-yl)benzimidazole.

Eur J Drug Metab Pharmacokinet

Istituto di Chimica Farmaceutica Applicata, Universita di Torino, Italy.

Published: September 1988

The in vitro metabolic transformation of the anti-inflammatory agent 2-(5-ethylpyridin-2-yl)benzimidazole (KB-1043) was studied with phenobarbital and 3-methylcholanthrene induced rat liver microsomal fractions containing an NADPH-generating system. The major metabolite was a benzylic oxidation product and a secondary metabolite was also recovered. The metabolites were isolated by TLC and HPLC techniques and identified by comparison with known pure compounds.

Download full-text PDF

Source
http://dx.doi.org/10.1007/BF03189928DOI Listing

Publication Analysis

Top Keywords

vitro metabolism
4
metabolism 2-5-ethylpyridin-2-ylbenzimidazole
4
2-5-ethylpyridin-2-ylbenzimidazole vitro
4
vitro metabolic
4
metabolic transformation
4
transformation anti-inflammatory
4
anti-inflammatory agent
4
agent 2-5-ethylpyridin-2-ylbenzimidazole
4
2-5-ethylpyridin-2-ylbenzimidazole kb-1043
4
kb-1043 studied
4

Similar Publications

Many lines of evidence suggest that circular RNAs (circRNAs) are closely associated with the occurrence and progression of colon cancer. The objective of this study was to investigate the regulatory effects and mechanisms of circ_0075829 on ferroptosis and immune escape in colon cancer. We utilized colon cancer cell lines and a xenograft mouse model to analyze the function of circ_0075829 in vitro and in vivo.

View Article and Find Full Text PDF

Triple-negative breast cancer (TNBC) is a highly aggressive subtype of breast malignancy. Although some patients benefit from immune checkpoint therapy, current treatment methods rely mainly on chemotherapy. It is imperative to develop predictors of efficacy and identify individuals who will be sensitive to particular treatment regimens.

View Article and Find Full Text PDF

Air-liquid interface culture combined with differentiation factors reproducing intestinal cell structure formation in vitro.

Biol Open

January 2025

Department of Clinical Pharmacy, Graduate School of Pharmaceutical Sciences, Nagoya City University, 3-1 Tanabe-dori, Mizuho-ku, Nagoya 467-8603, Japan.

Reproducing intestinal cells in vitro is important in pharmaceutical research and drug development. Caco-2 cells and human iPS cell-derived intestinal epithelial cells are widely used, but few evaluation systems can mimic the complex crypt-villus-like structure. We attempted to generate intestinal cells mimicking the three-dimensional structure from human iPS cells.

View Article and Find Full Text PDF

Wall shear stress modulates metabolic pathways in endothelial cells.

Metabolomics

January 2025

Laboratory of Applied Mass Spectrometry, Department of Cellular and Molecular Medicine, KU Leuven, Leuven, Belgium.

Introduction: Hemodynamic forces play a crucial role in modulating endothelial cell (EC) behavior, significantly influencing blood vessel responses. While traditional in vitro studies often explore ECs under static conditions, ECs are exposed to various hemodynamic forces in vivo. This study investigates how wall shear stress (WSS) influences EC metabolism, focusing on the interplay between WSS and key metabolic pathways.

View Article and Find Full Text PDF

ADC189 is a novel drug of cap-dependent endonuclease inhibitor. In our study, its antiviral efficacy was evaluated in vitro and in vivo, and compared with baloxavir marboxil and oseltamivir. A first-in-human phase I study in healthy volunteers included single ascending dose (SAD) and food effect (FE) parts.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!